Every 424B that Wearable Devices Ltd. (WLDS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow WLDS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full WLDS filings page.
Wearable Devices Ltd. (WLDS) launched a registered direct offering of 655,000 Ordinary Shares and Pre-Funded Warrants to purchase up to 575,000 shares. The Pre-Funded Warrants carry a $0.0001 exercise price and a 9.99% beneficial ownership cap. The combined purchase price is $2.67 per share and $2.6699 per pre-funded unit.
The company estimates net proceeds of approximately $2.9 million for working capital and general corporate purposes. A.G.P./Alliance Global Partners is acting as financial advisor; the fee table shows $3,284,042 in gross offering price, $262,723 in advisor fees, and $3,021,319 in proceeds before expenses.
In a concurrent private placement (not part of this prospectus), the same investor will receive 1,230,000 unregistered Warrants exercisable at $2.67 per share, effective upon shareholder approval, expiring five years after approval. Ordinary Shares outstanding were 5,960,770 as of October 29, 2025; Ordinary Shares to be outstanding after this offering are 6,615,770.
Wearable Devices (WLDS) amended its ATM program to $3,864,566 of ordinary shares under its Form F-3 with A.G.P., decreasing the prior $7,400,000 limit. Sales, if any, may be made as “at the market offerings” under Rule 415, with A.G.P. acting on a best efforts basis.
The company has sold $1,256,000 to date under the Sales Agreement. A.G.P. will receive a 3.0% commission on gross sales, and will be deemed an underwriter; indemnification applies as customary. WLDS shares trade on Nasdaq at $2.96 per share as of October 28, 2025. The aggregate market value of ordinary shares held by non‑affiliates was $54,829,754 as of October 29, 2025 under Form F‑3 I.B.5, and the company notes it has sold approximately $9,870,000 of securities in the past 12 months, leaving current I.B.5 capacity of $8,404,757.
Wearable Devices Ltd. prospectus supplement discloses financing and capitalization details and highlights material risks. The company reported an explanatory paragraph in its interim financial statements expressing substantial doubt about its ability to continue as a going concern. The document lists multiple classes of potentially dilutive securities, including options, warrants, pre-funded warrants, RSUs and reserved shares, with explicit counts such as 3,322,000 Ordinary Shares subject to shareholder approval for warrants, 564,059 RSUs outstanding, 98,589 IPO warrants, and additional warrants exercisable at $4.00 and $6.00 for 1,000,000 and 670,000 shares respectively. A pro forma capitalization table shows total shareholders' equity increasing to $20,104 on a pro forma basis after recent issuances described, and the assumed offering price used for illustrative pro forma calculations is $5.37 per share. The supplement also outlines permitted offering and distribution methods, material terms for warrants and units, and estimated offering expenses including $15,000 legal fees and $3,000 accounting fees.